Global 2023 - Players, Regions, Product Types, Application & Forecast Analysis
收藏theindustrystats.com2025-03-25 收录
下载链接：
https://theindustrystats.com/report/legal-marijuana-market/10320/?utm_source=google&utm_medium=datasets&utm_campaign=datasetsearch
下载链接
链接失效反馈官方服务：
资源简介：
Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period<table class='table'> <tr> <th>ATTRIBUTES</th> <th>DETAILS</th> </tr><tr> <td>STUDY PERIOD</td><td>2017-2030</td></tr><tr> <td>BASE YEAR</td><td>2023</td></tr><tr> <td>FORECAST PERIOD</td><td>2024-2030</td></tr><tr> <td>HISTORICAL PERIOD</td><td>2017-2022</td></tr><tr> <td>UNIT</td><td>VALUE (USD MILLION)</td></tr><tr> <td>KEY COMPANIES PROFILED</td><td>Canopy Growth Corporation, Aurora Cannabis, Aphria, Tilray, ABcann Medicinals, The Cronos Group, Maricann Group, Organigram Holding, Lexaria Corp, GW Pharmaceuticals, United Cannabis Corporation, Tikun Olam, Cannabis Sativa, The Lab, K.I.N.D. Concentrates, Emerald Health Therapeutics, MedReleaf Corp, CannTrust Holdings</td></tr><tr> <td>SEGMENTS COVERED</td><td style='text-transform:capitalize;'>By Product Type - Tetrahydrocannabinol (THC), Cannabidiol (CBD)<br>By Application - Chronic Pain, Mental Disorders, Cancer, Arthritis, Others<br>By Sales Channels - Direct Channel, Distribution Channel<br>By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa</td></tr></table>
近年来，产品市场体量呈上升趋势，预计在预测期内市场将显著扩张。<table class='table'> <tr> <th>属性</th> <th>详细信息</th> </tr><tr> <td>研究周期</td><td>2017-2030</td></tr><tr> <td>基准年份</td><td>2023</td></tr><tr> <td>预测周期</td><td>2024-2030</td></tr><tr> <td>历史周期</td><td>2017-2022</td></tr><tr> <td>单位</td><td>价值（亿美元）</td></tr><tr> <td>关键公司概览</td><td>Canopy Growth Corporation, Aurora Cannabis, Aphria, Tilray, ABcann Medicinals, The Cronos Group, Maricann Group, Organigram Holding, Lexaria Corp, GW Pharmaceuticals, United Cannabis Corporation, Tikun Olam, Cannabis Sativa, The Lab, K.I.N.D. Concentrates, Emerald Health Therapeutics, MedReleaf Corp, CannTrust Holdings</td></tr><tr> <td>涵盖的细分市场</td><td style='text-transform:capitalize;'>按产品类型 - 四氢大麻酚（THC），大麻二酚（CBD）<br>按应用 - 慢性疼痛，精神障碍，癌症，关节炎，其他<br>按销售渠道 - 直接渠道，分销渠道<br>按地理区域 - 北美洲，欧洲，亚太地区，南美洲，中东和非洲</td></tr></table>
提供机构：
theindustrystats.com
